The impact of fibrinogen structural alterations on its function in EM patients and matched controls was assessed by analyzing thrombin-catalyzed fibrin polymerization and fibrin susceptibility to plasmin-induced lysis. The gene discussed is PLG; the disease is erythema multiforme.